April 23 (Reuters) - Orion Oyj ORNBV.HE:
Q1 SALES EUR 354.6 MILLION VERSUS. ESTIMATE EUR 342.9 MILLION
Q1 EBITDA EUR 91.5 MILLION
Q1 OPERATING PROFIT EUR 77.9 MILLION VERSUS. ESTIMATE EUR 70.6 MILLION
Q1 BASIC EPS EUR 0.44
Q1 NET INCOME EUR 61.3 MILLION
Q1 PRETAX PROFIT EUR 76.8 MILLION
OUTLOOK 2025: NET SALES ARE ESTIMATED TO BE EUR 1,550 MILLION TO EUR 1,650 MILLION
NUBEQA® CONTINUED TO DRIVE GROWTH OF GROUP AND INNOVATIVE MEDICINES BUSINESS DIVISION
OUTLOOK 2025: OPERATING PROFIT IS ESTIMATED TO BE EUR 350 MILLION TO EUR 450 MILLION
BOTH ROYALTY INCOME AND PRODUCT SALES INCREASED SIGNIFICANTLY FROM COMPARISON PERIOD
NUBEQA®'S PRODUCT SALES GREW FROM PREVIOUS QUARTER AND WERE AT AN ALL-TIME HIGH SO FAR
US IMPORT TARIFFS CONTINUE TO BE A HOT TOPIC WORLDWIDE, AND THERE IS A LOT OF UNCERTAINTY AROUND TOPIC RIGHT NOW
Source text: ID:nGNE8xDRDc
Further company coverage: ORNBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))